AU9132091A - Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases - Google Patents

Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases

Info

Publication number
AU9132091A
AU9132091A AU91320/91A AU9132091A AU9132091A AU 9132091 A AU9132091 A AU 9132091A AU 91320/91 A AU91320/91 A AU 91320/91A AU 9132091 A AU9132091 A AU 9132091A AU 9132091 A AU9132091 A AU 9132091A
Authority
AU
Australia
Prior art keywords
pulmonary diseases
alpha interferon
oral inhalation
treat asthma
malignant proliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91320/91A
Inventor
Francis M Cuss
Keith B Nolop
Robert J Spiegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU9132091A publication Critical patent/AU9132091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU91320/91A 1990-12-21 1991-12-18 Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases Abandoned AU9132091A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63156590A 1990-12-21 1990-12-21
US63155290A 1990-12-21 1990-12-21
US631552 1990-12-21
US631565 1990-12-21

Publications (1)

Publication Number Publication Date
AU9132091A true AU9132091A (en) 1992-07-22

Family

ID=27091422

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91320/91A Abandoned AU9132091A (en) 1990-12-21 1991-12-18 Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases

Country Status (6)

Country Link
AU (1) AU9132091A (en)
IE (1) IE914444A1 (en)
IL (1) IL100415A0 (en)
MX (1) MX9102702A (en)
PT (1) PT99837A (en)
WO (1) WO1992011025A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271206B1 (en) 1996-09-12 2001-08-07 Valentis, Inc. Sonic nebulized nucleic acid/cationic liposome complexes and methods for pulmonary gene delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
AU601741B2 (en) * 1986-05-27 1990-09-20 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ES2052579T3 (en) * 1986-10-22 1994-07-16 Schering Corp USE OF INTERFERON ALPHA HUMAN RECOMBINANT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT AIDS VIRUSES.
WO1988009673A1 (en) * 1987-06-02 1988-12-15 Schering Corporation Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons
JPH0618784B2 (en) * 1988-07-05 1994-03-16 シェリング・コーポレーション Treatment of genital warts by the combined use of podophylline and recombinant DNA human alpha interferon
US4959210A (en) * 1988-11-01 1990-09-25 Schering Corporation Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
AU634511B2 (en) * 1988-12-01 1993-02-25 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
IL100415A0 (en) 1992-09-06
MX9102702A (en) 1992-06-01
WO1992011025A2 (en) 1992-07-09
WO1992011025A3 (en) 1992-09-17
PT99837A (en) 1992-12-31
IE914444A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
PL340994A1 (en) Method of administering therapeutic substances by inhalation and inhaler therefor
MY112098A (en) Therapeutic preparation for inhalation
IT8547939A0 (en) LIPOSOMES CONTAINING INTERLEUCIN, METHOD FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE IN CANCER DISEASES
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
AU3080489A (en) Improved pediatric asthmatic inhaler
HK1018595A1 (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis
HK1030157A1 (en) Use of consensus interferon and compositions comprising consensus interferon.
AU8910891A (en) Treatment of lung diseases
AU4357393A (en) Prophylactic and remedy for viral diseases in respiratory tract
AU9139091A (en) Oral administration of alpha interferon to treat lung malignancies
AU9132091A (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
IL65184A (en) Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
ZA919959B (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
DE3470002D1 (en) Use of l-fucose in the preparation of an inhalation composition and a process for preparing l-fucose
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
GB2170403B (en) Medicament for treatment of asthma and preparation thereof
PL316444A1 (en) Novel agent against viral diseases of respiratory tracts
AU5381890A (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
GB9124275D0 (en) New radical scavenging and antilipoperoxidant flavanolignans their preparation and formulations for therapeutic use
ZA852632B (en) Perhydrothiazepine derivatives,their preparation and their therapeutic use
AU609435B2 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
AU5374386A (en) Unstrurated cycloaliphatic derivatives, their preparation and their use in therapeutic and cosmetic compositions
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
PL284057A1 (en) Oral and nasal inhaler